Beauty Health (NASDAQ:SKIN) Announces Quarterly Earnings Results

Beauty Health (NASDAQ:SKIN) announced its quarterly earnings data on Wednesday. The company reported ($0.08) EPS for the quarter, beating analysts’ consensus estimates of ($0.10) by $0.02, Zacks reports. Beauty Health had a negative return on equity of 44.83% and a negative net margin of 8.11%. Beauty Health updated its Q1 2025 guidance to EPS and its FY 2025 guidance to EPS.

Beauty Health Stock Up 4.4 %

Shares of NASDAQ SKIN traded up $0.06 during mid-day trading on Wednesday, reaching $1.42. The company had a trading volume of 649,947 shares, compared to its average volume of 1,325,838. The company has a debt-to-equity ratio of 9.23, a quick ratio of 5.57 and a current ratio of 6.56. Beauty Health has a 12-month low of $0.91 and a 12-month high of $5.17. The stock has a fifty day moving average of $1.59 and a two-hundred day moving average of $1.57. The company has a market capitalization of $176.25 million, a price-to-earnings ratio of -3.38 and a beta of 0.84.

Wall Street Analyst Weigh In

Separately, Canaccord Genuity Group raised their price objective on Beauty Health from $1.25 to $1.75 and gave the company a “hold” rating in a research report on Wednesday, November 13th. One investment analyst has rated the stock with a sell rating, three have issued a hold rating and one has assigned a buy rating to the company’s stock. According to MarketBeat.com, the company has an average rating of “Hold” and an average price target of $2.55.

Beauty Health Company Profile

The Beauty Health Company designs, develops, manufactures, markets, and sells aesthetic technologies and products worldwide. The company's flagship product includes HydraFacial that enhance the skin to cleanse, extract, and hydrate the skin with proprietary solutions and serums. Its products also comprise Syndeo, a Delivery System designs to connects providers to the consumer's preferences to create a more personalized experience; consumables, such as single-use tips, solutions, and serums used to provide a hydrafacial treatment; SkinStylus SteriLock Microsystem, a microneedling device used for the treatment of enhancing appearance of surgical or traumatic hypertrophic scars on the abdomen and facial acne scarring in Fitzpatrick skin types I, II, and III; and Keravive, a treatment for scalp health.